Enterovirus 71: Epidemiology, pathogenesis and management

Expert Review of Anti-Infective Therapy

Volumn 7, Issue 6, 2009, Pages 735-742

  Wang, Shih Min ^b   Liu, Ching Chuan ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Brainstem encephalitis; Cytokine; Enterovirus 71; Hand foot mouth disease; Intravenous IgG; Milrinone; Pulmonary edema

Indexed keywords

ALLOPHYCOCYANIN; DNA VACCINE; IMMUNOGLOBULIN G; INACTIVATED VACCINE; LACTOFERRIN; MILRINONE; POLIOMYELITIS VACCINE; IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR; VASODILATOR AGENT;

AGE DISTRIBUTION; AUTONOMIC NEUROPATHY; BLOOD VESSEL PERMEABILITY; BRAIN STEM; CLINICAL FEATURE; COXSACKIE VIRUS INFECTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; ENTEROVIRUS 71; HAND FOOT AND MOUTH DISEASE; HUMAN; INCIDENCE; INFECTION CONTROL; LUNG EDEMA; MORTALITY; NONHUMAN; PATHOGENESIS; REVIEW; RNA INTERFERENCE; SYMPATHETIC TONE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT INDICATION; VASOMOTOR REFLEX; VIRUS ENCEPHALITIS; ADULT; ARTICLE; CHILD; DISEASE MANAGEMENT; ENTEROVIRUS; ENTEROVIRUS INFECTION; INFANT; PARAPLEGIA; PATHOGENICITY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; TAIWAN; VIROLOGY;

ADULT; BRAIN STEM; CHILD; CHILD, PRESCHOOL; DISEASE MANAGEMENT; ENCEPHALITIS, VIRAL; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; MILRINONE; PARAPLEGIA; PULMONARY EDEMA; TAIWAN; VASODILATOR AGENTS;

EID: 70350464760     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/ERI.09.45     Document Type: Review

References (55)

1. Cherry JD. Enteroviruses and Parechoviruses. In: Textbook of Pediatric Infectious Diseases (5th Edition). Feign RD, Cherry JD (Eds.). WB Saunders, PA, USA 1984-2041 (2004).
2. Schmidt NJ, Lennett EH, Ho HH. An apparently new enterovirus isolated from patients with disease of central nervous system. J. Infect. Dis. 129, 304-309 (1974).
3. Ministry of Health, The Executive Yuan, Taiwan, ROC. Deaths among children during an outbreak of hand, foot, and mouth disease - Taiwan, Republic of China, April-July 1998. MMWR Morb. Mortal. Wkly. Rep. 47, 629-632 (1998).
4. Wang SM, Liu CC, Tseng HW et al. Clinical spectrum of enterovirus 71 infection of children in southern Taiwan, with an emphasis on the neurological complications. Clin. Infect. Dis. 29, 184-190 (1999). •• First study reporting the clinical characterization of enterovirus (EV)71 infection in Taiwan.
5. Liu CC, Tseng HW, Wang SM, Wang JR, Su IJ. An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. 17, 23-30 (2000).
6. Ho M, Chen ER, Hsu KH et al. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 341, 929-935 (1999). •• Important study on epidemiological aspects of EV71 infection in Taiwan.
7. Lum LCS, Wong KT, Lam SK et al. Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 133, 795-798 (1998).
8. Pérez-Vélez CM, Anderson MS, Robinson CC et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin. Infect. Dis. 45, 950-957 (2007).
9. Shindarov LM, Chumakov MP, Voroshilova MK et al. Epidemiological, clinical and patholomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J. Hyg. Epidemiol. Microbiol. Immunol. 23, 284-295 (1979).
10. Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch. Virol. 71, 217-227 (1982). (Pubitemid 12072656)
11. Hsiung GD, Wang JR. Enterovirus infection with special reference to enterovirus 71. J. Microbiol. Immunol. Infect. 33, 1-8 (2000).
12. Strikas RA, Anderson LJ, Parker RA. Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J. Infect. Dis. 153, 346-351 (1986).
13. Lu CY, Lee CY, Kao CL, et al. Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J. Med. Virol. 67, 217-223 (2002) • Reports seroepidemiological survey, including incidence and case-fatality rates of EV71 infection.
14. Ooi EE, Phoon MC, Ishak B, Chan SH. Seroepidemiology of human enterovirus 71, Singapore. Emerg. Infect. Dis. 8, 995-997 (2002).
15. Chang LY, Tsao KC, Hsia SH et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 291, 222-227 (2004). •• Important prospective, family-cohort study on EV71 household transmission rates.
16. Brown BA, Oberste MS, Alexander JP Jr, Kennett ML, Pallansch MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 73, 9969-9975 (1999).
17. Wang JR, Tuan YC, Tsai HP, Yan JJ, Liu CC, Su IJ. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and mouth disease in Taiwan between 1998 and 2000. J. Clin. Microbiol. 40, 10-15 (2002).
18. Huang YP, Lin TL, Kuo CY et al. The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. Virus Res. 137, 206-212 (2008). • Recent study describing the circulation of EV71 subgenogroups in Taiwan.
19. Huang SC, Hsu YW, Wang HC et al. Appearance of intratypic recombination of enterovirus 71 in Taiwan from 2002 to 2005. Virus Res. 131, 250-259 (2008).
20. Shimizu H, Utama A, Onnimala N et al. Molecular epidemiology of enterovirus 71 infection in the Western Pacific region. Pediatr. Intl. 46, 231-235 (2004). •• Important study on molecular epidemiological analyses of EV71 isolates in the Western Pacific region. (Pubitemid 38526625)
21. Mizuta K, Abiko C, Murata T et al. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J. Clin. Microbiol. 43, 6171-6175 (2005).
22. Tu PV, Thao NTT, Perera D et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg. Infect. Dis. 13, 1733-1741 (2007). (Pubitemid 350126202)
23. Zhang Y, Tan XJ, Wang HY et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J. Clin. Virol. 44, 262-267 (2009).
24. Lin TY, Chang LY, Hsia SH et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin. Infect. Dis. 34(Suppl. 2), S52-S57 (2002).
25. Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurological complications in children with enterovirus 71 infection. N. Engl. J. Med. 341, 936-942 (1999).
26. Yan JJ, Wang JR, Liu CC, Yang HB, Su IJ. An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J. Clin. Virol. 17, 13-22 (2000).
27. Theodore J, Robin ED. Pathogenesis of neurogenic pulmonary oedema. Lancet 2, 749-751 (1975).
28. Wu JM, Wang JN, Tsai YC et al. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics 109, E26 (2002).
29. Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, Yang KD. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta. Paediatr. 91, 632-635 (2002).
30. Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin. Infect. Dis. 36, 269-274 (2003). • Comparing the cerebrospinal fluid and serum levels of cytokines in patients with EV71 infection.
31. Wang SM, Lei HY, Huang KJ et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: the roles of cytokines and cellular immune activation in patients with pulmonary edema. J. Infect. Dis. 188, 564-570 (2003). •• Important study on immune mechanisms in the pathogenesis of brainstem encephalitis caused by EV71. The authors infer that an extensive peripheral and CNS inflammatory response with abnormal cytokine production and lymphocyte depletion is responsible for the pathogenesis of EV71-associated pulmonary edema.
32. Wang SM, Lei HY, Yu CK et al. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J. Infect. Dis. 198, 1002-1006 (2008). • Recent study on the characteristics of the chemokine responses in the blood and cerebrospinal fluid of patients with EV71-associated brainstem encephalitis by disease severity.
33. Wang SM, Lei HY, Su LY et al. Cerebrospinal fluid cytokines in various severity of enterovirus 71 brainstem encephalitis and echovirus meningitis. Clin. Microbiol. Infect. 13, 677-682 (2007).
34. Yang KD, Yang MY, Li CC et al. Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. J. Infect. Dis. 183, 850-856 (2001).
35. Chen LC, Shyu HW, Chen SH et al. Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells. J. Med. Virol. 78, 780-786 (2006).
36. Chang SC, Lin JY, Lo LYC, Li ML, Shih SR. Diverse apoptotic pathways in enterovirus 71-infected cells. J. NeuroVirol. 10, 338-349 (2004).
37. Wong KT, Munisamy B, Ong KC et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J. Neuropathol. Exp. Neurol. 67, 162-169 (2008).
38. Chen YC, Yu CK, Wang YF, Liu CC, Su IJ, Lei HY. A murine oral enterovirus 71 infection model with central nervous system involvement. J. Gen. Virol. 85, 69-77 (2004). •• First study to establish a mouse EV71 infection model with CNS involvement, the authors infer that EV71 might use the active retrograde axonal transport system to enter the CNS.
39. Nagata N, Shimizu H, Ami Y et al. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J. Med. Virol. 67, 207-216 (2002). (Pubitemid 34493434)
40. Huang MC, Wang SM, Hsu YW, Lin HC, Chi CY, Liu CC. Long-term cognitive and motor deficits following enterovirus 71 brainstem encephalitis in children. Pediatrics 118, e1785-e1788 (2006).
41. Wang SM, Lei HY, Huang MC et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J. Clin. Virol. 37, 47-52 (2006). •• First study reporting the changes in cytokine profiles associated with administration of intravenous immunoglobulin in patients with EV71-associated brainstem encephalitis. The authors infer that intravenous immunoglobulin might be considered to have a therapeutic role in EV71-associated brainstem encephalitis complicated with autonomic nervous system dysfunction.
42. Wang SM, Lei HY, Huang MC et al. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr. Pulmonol. 39, 219-223 (2005). •• First study reporting the therapeutic effect of milrinone, a phosphodiesterase inhibitor, in the treatment of patients with EV71-induced pulmonary edema. The authors infer that milrinone therapy is associated with decreased mortality.
43. Chang LY, Huang LM, Gau S et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 356, 1226-1234 (2007). (Pubitemid 46465598)
44. Rotbart HA. Treatment of picornavirus infections. Antivir. Res. 53, 83-98 (2002).
45. Liu ML, Lee YP, Wang YF et al. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 86, 3263-3269 (2005).
46. Pevear DC, Tull TM, Seipel ME, Groarke JM. Activity of pleconaril against enteroviruses. Antimicrob. Agents Chemother. 43, 2109-2115 (1999).
47. Shia KS, Li WT, Chang CM et al. Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors. J. Med. Chem. 45, 1644-1655 (2002). • Important study on the discovery of a novel series of imidazolidinone derivatives showing significant anti-EV71 activity.
48. Li ZH, Li CM, Ling P et al. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J. Infect. Dis. 197, 854-857 (2008).
49. Lu WW, Hsu YY, Yang JY, Kung SH. Selective inhibition of enterovirus 71 replication by short hairpin RNAs. Biochem. Biophys. Res. Commun. 325, 494-499 (2004). • Demonstrates the possible feasibility of RNA interference therapy for EV71-associated diseases.
50. Shih SR, Tsai KN, Li YS, Chueh CC, Chan EC. Inhibition of enterovirus 71-induced apoptosis by allophycocyanin isolated from a blue-green alga spirulina platensis. J. Med. Virol. 70, 119-125 (2003).
51. Lin TY, Chu C, Chiu CH. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J. Infect. Dis. 186, 1161-1164 (2002). (Pubitemid 35177120)
52. Chumakov MP, Voroshilova MK, Shindarov LM et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch. Virol. 60, 329-340 (1979).
53. Guang D, Foo W, Alonso S et al. Identification of neutralizing linear epitopes from the VP1 capsid protein of enterovirus 71 using synthetic peptides. Virus Res. 125, 61-68 (2007). • Reports a candidate for an effective synthetic peptide-based vaccine against various subgenogroups of EV71. (Pubitemid 46413387)
54. Chen HL, Huang JY, Chu TW et al. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine 26, 2882-2889 (2008).
55. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20 895-904 (2002). •• Important study comparing the inactivated virus vaccine with subunit vaccines for its ability to elicit maternal antibody and to provide protection against EV71 infection in mice. (Pubitemid 34015831)